Cancer pain: where are we now?

被引：49
|
作者：
Magee, David [1 ]
Bachtold, Sabina [1 ]
Brown, Matthew [1 ,2 ]
Farquhar-Smith, Paul [1 ]
机构：
[1] Royal Marsden Hosp, Dept Pain Med, Fulham Rd, London SW3 6JJ, England
[2] Inst Canc Res, Targeted Approaches Canc Pain Grp, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England
来源：
PAIN MANAGEMENT | 2019年 / 9卷 / 01期
关键词：
cancer pain; large-scale data; pain assessment; pain management; recent advances; PERIPHERAL NEUROPATHIC PAIN; INDUCED ORAL MUCOSITIS; PERSISTENT POSTSURGICAL PAIN; INHIBITOR-INDUCED ARTHRALGIA; EARLY PALLIATIVE CARE; QUALITY-OF-LIFE; BREAST-CANCER; RADIATION-THERAPY; DOUBLE-BLIND; NERVE DAMAGE;
D O I：
10.2217/pmt-2018-0031
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Increasing numbers of those living with and beyond cancer presents a clinical challenge for pain specialists. A large proportion of these patients experience pain secondary to their disease or its treatment, impeding rehabilitation and significantly impacting upon their quality of life. The successful management of this pain presents a considerable challenge. This review aims to outline current concepts and treatment options, while considering nuances within pain assessment and the use of large-scale data to help guide further advances.
引用
收藏
页码：63 / 79
页数：17
相关论文
共 50 条
  • [21] Immunotherapy for head and neck cancer: where are we now and where are we going?
    Bauml, Joshua M.
    Aggarwal, Charu
    Cohen, Roger B.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [22] Early detection of pancreatic cancer: Where are we now and where are we going?
    Zhou, Bin
    Xu, Jian-Wei
    Cheng, Yu-Gang
    Gao, Jing-Yue
    Hu, San-Yuan
    Wang, Lei
    Zhan, Han-Xiang
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (02) : 231 - 241
  • [23] Immunotherapy for esophageal cancer: Where are we now and where can we go
    Shoji, Yoshiaki
    Koyanagi, Kazuo
    Kanamori, Kohei
    Tajima, Kohei
    Ogimi, Mika
    Ninomiya, Yamato
    Yamamoto, Miho
    Kazuno, Akihito
    Nabeshima, Kazuhito
    Nishi, Takayuki
    Mori, Masaki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (19) : 2496 - 2501
  • [24] Prostate cancer screening: where are we now?
    Light, Alexander
    Elhage, Oussama
    Marconi, Lorenzo
    Dasgupta, Prokar
    BJU INTERNATIONAL, 2019, 123 (06) : 916 - 917
  • [25] Lead and cancer in humans: Where are we now?
    Steenland, K
    Boffetta, P
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2000, 38 (03) : 295 - 299
  • [26] Cancer: Where we are now and goals for 2015
    Woolam, GL
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (03) : 155 - 156
  • [27] Where are we now with prostate cancer diagnosis?
    Wong, Lih-Ming
    Neal, David E.
    TRENDS IN UROLOGY & MENS HEALTH, 2010, 1 (01) : 18 - 20
  • [28] Immunotherapy and Hepatocellular Cancer: Where Are We Now?
    Valery, Marine
    Cervantes, Baptiste
    Samaha, Ramy
    Gelli, Maximiliano
    Smolenschi, Cristina
    Fuerea, Alina
    Tselikas, Lambros
    Klotz-Prieux, Caroline
    Hollebecque, Antoine
    Boige, Valerie
    Ducreux, Michel
    CANCERS, 2022, 14 (18)
  • [29] Quackery Nuts and cancer: where are we now?
    Stebbing, Justin
    LANCET ONCOLOGY, 2013, 14 (12): : 1161 - 1162
  • [30] Colorectal Cancer Biomarkers: Where Are We Now?
    Gonzalez-Pons, Maria
    Cruz-Correa, Marcia
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
12345